News + Filings Transactions Holdings
|
|
Cormorant Asset Management, LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Prometheus Biosciences, Inc.
| RXDX | Common | 0 | -2,090,000 | 0 | -229,900,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Revolution Medicines, Inc.
| RVMD | Common | 0 | -1,895,066 | 0 | -45,140,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Altimmune, Inc.
| ALT | COM NEW | 0 | -2,600,000 | 0 | -42,770,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Ventyx Biosciences, Inc.
| VTYX | Common | 0 | -1,080,643 | 0 | -35,434,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Tango Therapeutics, Inc.
| TNGX | Common | 0 | -4,116,949 | 0 | -29,848,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Rain Oncology Inc.
| RAIN | Common | 0 | -2,978,660 | 0 | -23,829,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Monte Rosa Therapeutics, Inc.
| GLUE | Common | 0 | -2,893,717 | 0 | -22,021,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
VectivBio Holding AG
| VECT | Common | 0 | -2,536,617 | 0 | -21,980,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Amylyx Pharmaceuticals, Inc.
| AMLX | Common | 0 | -550,000 | 0 | -20,323,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Mirati Therapeutics, Inc.
| MRTX | COM | 0 | -400,000 | 0 | -18,124,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
PLIANT THERAPEUTICS, INC.
| PLRX | Common | 0 | -782,788 | 0 | -15,131,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Prime Medicine, Inc.
| PRME | Common | 0 | -734,350 | 0 | -13,644,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
CYTOKINETICS INC
| CYTK | COM NEW | 0 | -296,000 | 0 | -13,563,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Viking Therapeutics, Inc.
| VKTX | COM | 0 | -700,000 | 0 | -6,580,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Altimmune, Inc.
| ALT | CALL | 0 | -400,000 | 0 | -6,580,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 0 | -50,000 | 0 | -6,107,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Poseida Therapeutics, Inc.
| PSTX | Common | 0 | -1,150,000 | 0 | -6,095,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Adicet Bio, Inc.
| ACET | Common | 0 | -600,000 | 0 | -5,364,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Icosavax, Inc.
| ICVX | Common | 0 | -643,825 | 0 | -5,112,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Keros Therapeutics, Inc.
| KROS | Common | 0 | -100,000 | 0 | -4,802,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Eledon Pharmaceuticals, Inc.
| ELDN | COMMON | 0 | -1,217,882 | 0 | -2,777,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Elevation Oncology, Inc.
| ELEV | COM | 0 | -1,952,032 | 0 | -1,854,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
X4 Pharmaceuticals, Inc
| XFOR | Common | 0 | -1,628,980 | 0 | -1,618,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Chemomab Therapeutics Ltd.
| CMMB | SPONSORED ADS | 0 | -288,169 | 0 | -922,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Talaris Therapeutics, Inc.
| TALS | Common | 0 | -900,649 | 0 | -919,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Pyxis Oncology, Inc.
| PYXS | Common | 0 | -668,854 | 0 | -896,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Y-mAbs Therapeutics, Inc.
| YMAB | Common | 0 | -150,000 | 0 | -732,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Orchard Therapeutics plc
| ORTX | Common | 0 | -256,649 | 0 | -95,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|